Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal a Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy With Epirubicin Plus Paclitaxel
PLoS ONE - United States
doi 10.1371/journal.pone.0104870
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 19, 2014
Authors
Publisher
Public Library of Science (PLoS)